Grifols

GRFS NASDAQ
22.05
-0.05
-0.23%
After Hours: 22.05 0 0.00% 16:00 08/20 EDT
Open
22.21
Prev Close
22.10
High
22.29
Low
21.98
Volume
1.11M
Avg Vol (3M)
1.48M
52 Week High
23.03
52 Week Low
17.42
% Turnover
0.16%
Market Cap
14.99B
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Grifols GRFS stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Grifols SA is a Spain-based company engaged in the biopharmaceuticals manufacture. The Company’s activities are divided into four business segments: Bioscience, Hospital, Diagnostic and Raw materials. The Bioscience division focuses on the research, development, manufacturing and marketing of products derived from human plasma for therapeutic use. The Hospital division offers non-biological pharmaceutical products and medical supplies for hospital pharmacy. The Diagnostic division provides clinical analysis and laboratory testing tools to laboratories, hospitals and blood banks. The Raw materials division includes sales of intermediate biological products, as well as manufacturing services to third parties. The Company operates production facilities in Spain, the United States, Mexico and Australia, among others. It controls numerous subsidiaries, such as Kiro Grifols SL.
MORE >

Recently

Name
Price
%Change